{"id":"W2023275561","doi":"10.1002/cncr.20455","title":"Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone‐refractory prostate carcinoma","year":2004,"lang":"en","type":"article","venue":"Cancer","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Visual analogue scale; Prostate cancer; Doxorubicin; Prostate; Randomized controlled trial; Prospective cohort study; Chemotherapy; Toxicity; Cancer; Refractory (planetary science); Internal medicine; Surgery; Gastroenterology; Urology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002472622,0.001716852,0.00208777,0.0004615115,0.0004378223,0.0009807775,0.0009190851,0.001863364,0.006744428],"category_scores_gemma":[0.002180835,0.0008374095,0.0009829754,0.0004755143,0.001558434,0.0009908836,0.0004475616,0.002788014,0.001202603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007156336,"about_ca_system_score_gemma":0.001677901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007148638,"about_ca_topic_score_gemma":0.001384279,"domain_scores_codex":[0.9991435,0.0005390861,0.00004366349,0.0001168793,0.00005634113,0.0001005162],"domain_scores_gemma":[0.9984496,0.0003990261,0.0003455421,0.0001612352,0.00008575725,0.0005587832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9733965,0.01189727,0.0008564744,0.0001981583,0.0002866589,0.00004642952,0.0000533192,0.0004284445,0.003210458,0.000103211,0.0005264686,0.008996685],"study_design_scores_gemma":[0.9357423,0.06254132,0.0007799662,0.000008303821,0.00006332405,0.00002053856,0.00001135613,0.0002855068,0.0002049861,0.00006271315,0.0002729833,0.000006553758],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847738,0.001928961,0.0007880461,0.0008189298,0.0005200586,0.008859836,0.0007892435,0.00009277137,0.001428475],"genre_scores_gemma":[0.9806904,0.001262516,0.002017889,0.001444645,0.0003725159,0.01070687,0.001055003,0.00002235596,0.002427758],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006744428,"threshold_uncertainty_score":0.02256233,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01137680616757674,"score_gpt":0.2714741012855239,"score_spread":0.2600972951179471,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}